Personal information

Activities

Employment (2)

Institut Paoli-Calmettes: Marseille, Provence-Alpes-Côte d'Azu, FR

2019-05 to present | Medical biologist (Oncogenetic)
Employment
Source: Self-asserted source
Anne Sophie Alary

Assistance Publique - Hôpitaux de Paris: Paris, Île-de-France, FR

2016-02-05 to 2019-05 (Hematology)
Employment
Source: Self-asserted source
Anne Sophie Alary

Works (12)

Accreditation strategy for rare somatic molecular abnormalities detected or quantified by polymerase chain reaction: GBMHM recommendations.

Annales de biologie clinique
2019-12-01 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Development of molecular analysis by digital PCR for clinical practice: positioning, current applications and perspectives.

Annales de biologie clinique
2019-12-01 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Phenotypic landscape of granulocytes and monocytes by multiparametric flow cytometry: A prospective study of a 1-tube panel strategy for diagnosis and prognosis of patients with MDS.

Cytometry. Part B, Clinical cytometry
2019-09-09 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Paraneoplastic Hyperleukocytosis Mimicking Hematologic Malignancy Revealing a Localized Lung Cancer.

The Annals of thoracic surgery
2019-08-10 | Journal article
Source: Self-asserted source
Anne Sophie Alary

A variant erythroferrone disrupts iron homeostasis in SF3B1 -mutated myelodysplastic syndrome

Science Translational Medicine
2019-07-10 | Journal article
Contributors: Sabrina Bondu; Anne-Sophie Alary; Carine Lefèvre; Alexandre Houy; Grace Jung; Thibaud Lefebvre; David Rombaut; Ismael Boussaid; Abderrahmane Bousta; François Guillonneau et al.
Source: check_circle
Crossref

Impact of genotype in relapsed and refractory acute myeloid leukaemia patients treated with clofarabine and cytarabine: a retrospective study.

British journal of haematology
2019-06-18 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Establishing assay-specific 97.5th percentile upper reference limit for serum D-2-hydroxyglutarate for the management of patients with acute myeloid leukemia.

Clinical chemistry and laboratory medicine
2019-03-01 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Dyserythropoiesis evaluated by the RED score and hepcidin:ferritin ratio predicts response to erythropoietin in lower-risk myelodysplastic syndromes.

Haematologica
2018-10-04 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Development of digital PCR molecular tests for clinical practice: principles, practical implementation and recommendations.

Annales de biologie clinique
2018-10-01 | Journal article
Source: Self-asserted source
Anne Sophie Alary

CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.

British journal of haematology
2018-09-10 | Journal article
Source: Self-asserted source
Anne Sophie Alary

Molecular dissection of engraftment in a xenograft model of myelodysplastic syndromes.

Oncotarget
2018-02-20 | Journal article
Source: Self-asserted source
Anne Sophie Alary

The role of genetic factors in patients with hepatocellular carcinoma and iron overload - a prospective series of 234 patients.

Liver international : official journal of the International Association for the Study of the Liver
2015-11-07 | Journal article
Source: Self-asserted source
Anne Sophie Alary